Property | Value |
?:abstract
|
-
The clinical manifestations of COVID-19 are mainly respiratory symptoms, but some patients present with cardiovascular system disease such as palpitations and shortness of breath as the first or secondary symptoms. In this paper, we describe the characteristics of SARS-CoV‑2 and its functional receptor angiotensin-converting enzyme 2 (ACE2). Furthermore, we explore the impact of virus-induced myocardial damage, decreased ACE2 activity, immune imbalance, hypoxemia, and heart damage caused by antiviral drugs.
|
?:creator
|
|
?:doi
|
-
10.1007/s00059-020-04989-x
|
?:doi
|
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/c3bce253dd12c9d0aa11f402d14129fc2f5ae49b.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7537586.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system
|
?:type
|
|
?:year
|
|